NCT07181824View on ClinicalTrials.gov

VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

September 24, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2025

Conditions

Pneumonia Ventilator Associated

Interventions

OTHER

Diagnostic tedst

"* Radiologic signs: 2 consecutive thorax x-ray with new onset pneumonia AND~* One of the following criteria~ * Fever \>38,3°C without any other cause~ * Leucocytes \< 4000/mm3 or ≥ 12000 /mm3~* AND at least two of the following~ * Purulent secretions~ * Cough or dyspnoea~ * Desaturation or increase in FiO2 (+20%)"

Trial Locations (1)

91100

Centre Hospitalier Sud Francilien, Corbeil-Essonnes

All Listed Sponsors

lead

Centre Hospitalier Sud Francilien

OTHER

NCT07181824 - VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024 | Biotech Hunter | Biotech Hunter